Publications by authors named "Grover P Miller"

Claim this Profile
T
The resurgence of synthetic cannabinoid receptor agonists as adulterants in the Era of Cannabis legalization: Lessons from prior epidemics and clinical implications.
Austin T Jones, Alaa Marwan Abu Taha, Grover P Miller

Neurosci Biobehav Rev· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioactivation and reactivity research advances - 2023 year in review.
Shuai Wang, Upendra A Argikar, Maria Chatzopoulou, Sungjoon Cho, Rachel D Crouch, Grover P Miller

Drug Metab Rev· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioactivation and reactivity research advances - 2022 year in review‡.
Shuai Wang, Upendra A Argikar, Lionel Cheruzel, Sungjoon Cho, Rachel D Crouch, Grover P Miller

Drug Metab Rev· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biotransformation research advances - 2022 year in review.
S Cyrus Khojasteh, Upendra A Argikar, Lionel Cheruzel, Sungjoon Cho, Rachel D Crouch, Grover P Miller

Drug Metab Rev· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Advancements in computational studies of drug toxicity.
Noah R Flynn, Grover P Miller, S Joshua Swamidass

Front Pharmacol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of cytochrome P450 3A4-mediated metabolism in sorafenib and lapatinib hepatotoxicity.
Mitchell R McGill, Yihong J Kaufman, Francesca V LoBianco, Mary A Schleiff, Nukhet Aykin-Burns, Grover P Miller

Livers· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioactivation and reactivity research advances - 2021 year in review.
Klarissa D Jackson, Upendra A Argikar, Sungjoon Cho, Rachel D Crouch, James P Driscoll, Grover P Miller

Drug Metab Rev· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar 5F-APINACA Metabolism between CD-1 Mouse and Human Liver Microsomes Involves Different P450 Cytochromes.
Samantha V Crosby, Izzeldin Y Ahmed, Laura R Osborn, Zeyuan Wang, Mary A Schleiff, Grover P Miller

Metabolites· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Novel Reductive Elimination Pathway for 10-Hydroxywarfarin.
Dakota L Pouncey, Dustyn A Barnette, Riley W Sinnott, Sarah J Phillips, Noah R Flynn, Grover P Miller

Front Pharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP2C9 and 3A4 play opposing roles in bioactivation and detoxification of diphenylamine NSAIDs.
Mary Alexandra Schleiff, Samantha Crosby, Madison Blue, Benjamin Mark Schleiff, Gunnar Boysen, Grover Paul Miller

Biochem Pharmacol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel advances in biotransformation and bioactivation research - 2020 year in review.
S Cyrus Khojasteh, Upendra A Argikar, James P Driscoll, Carley J S Heck, Lloyd King, Grover P Miller

Drug Metab Rev· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning liver-injuring drug interactions with non-steroidal anti-inflammatory drugs (NSAIDs) from a retrospective electronic health record (EHR) cohort.
Arghya Datta, Noah R Flynn, Dustyn A Barnette, Keith F Woeltje, Grover P Miller

PLoS Comput Biol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-Methyl-1,2,3-Triazoles as -Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Improved Selectivity.
Huarui Cui, Angela S Carlson, Mary A Schleiff, Anand Divakaran, Jorden A Johnson, Grover P Miller

J Med Chem· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impacts of diphenylamine NSAID halogenation on bioactivation risks.
Mary Alexandra Schleiff, Sasin Payakachat, Benjamin Mark Schleiff, S Joshua Swamidass, Gunnar Boysen, Grover Paul Miller

Toxicology· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioactivation of Isoxazole-Containing Bromodomain and Extra-Terminal Domain (BET) Inhibitors.
Noah R Flynn, Michael D Ward, Mary A Schleiff, Corentine M C Laurin, Rohit Farmer, Grover P Miller

Metabolites· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meloxicam methyl group determines enzyme specificity for thiazole bioactivation compared to sudoxicam.
Dustyn A Barnette, Mary A Schleiff, Arghya Datta, Noah Flynn, S Joshua Swamidass, Grover P Miller

Toxicol Lett· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of Multiple Bioactivation Pathways for Meclofenamate as Revealed through Modeling and Reaction Kinetics.
Mary Alexandra Schleiff, Noah R Flynn, Sasin Payakachat, Benjamin Mark Schleiff, Anna O Pinson, Grover P Miller

Drug Metab Dispos· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of Competing Metabolic Pathways for 5F-APINACA Based on Quantitative Kinetics.
Anna O Pinson, Dakota L Pouncey, Mary A Schleiff, William E Fantegrossi, Paul L Prather, Grover P Miller

Molecules· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel advances in biotransformation and bioactivation research-2019 year in review.
S Cyrus Khojasteh, James P Driscoll, Klarissa D Jackson, Grover P Miller, Kaushik Mitra

Drug Metab Rev· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual mechanisms suppress meloxicam bioactivation relative to sudoxicam.
Dustyn A Barnette, Mary A Schleiff, Laura R Osborn, Noah Flynn, Matthew Matlock, Grover P Miller

Toxicology· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive kinetic and modeling analyses revealed CYP2C9 and 3A4 determine terbinafine metabolic clearance and bioactivation.
Dustyn A Barnette, Mary A Davis, Noah Flynn, Anirudh S Pidugu, S Joshua Swamidass, Grover P Miller

Biochem Pharmacol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Time-Embedding Network Models the Ontogeny of 23 Hepatic Drug Metabolizing Enzymes.
Matthew K Matlock, Abhik Tambe, Jack Elliott-Higgins, Ronald N Hines, Grover P Miller

Chem Res Toxicol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP2C19 and 3A4 Dominate Metabolic Clearance and Bioactivation of Terbinafine Based on Computational and Experimental Approaches.
Mary A Davis, Dustyn A Barnette, Noah R Flynn, Anirudh S Pidugu, S Joshua Swamidass, Grover P Miller

Chem Res Toxicol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biotransformation and bioactivation reactions - 2018 literature highlights.
S Cyrus Khojasteh, Namandjé N Bumpus, James P Driscoll, Grover P Miller, Kaushik Mitra

Drug Metab Rev· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Withdrawal: The role of ERp44 in maturation of serotonin transporter protein.
Samuel Freyaldenhoven, Yicong Li, Arif M Kocabas, Enrit Ziu, Serra Ucer, Grover P Miller

J Biol Chem· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis